News &amp; Updates

The use of antibiotic therapy for 30 days following robot-assisted radical cystectomy (RARC) results in reduced 90-day urinary tract infections (UTIs), infectious complications, UTI-related readmissions, and costs without an increase in adverse events (AEs), a study has shown.

Antibiotics use after RARC lowers 90-day UTIs, complications

07 Aug 2025

Antibiotics prevent complications in hypospadias repair

Antibiotic prophylaxis prior to hypospadias repair results in reduced complications in longer procedures, reports a study.

Antibiotics prevent complications in hypospadias repair

Hormonal, nonhormonal IUDs equally effective at preventing pregnancies

For emergency contraception, both the levonorgestrel 52 mg and copper T380A intrauterine devices (IUDs) help prevent a high proportion of expected pregnancies, according to a study.

Hormonal, nonhormonal IUDs equally effective at preventing pregnancies

Follitropin delta as good as follitropin alfa for ovarian stimulation in IVF

Follitropin delta 15 µg/day and follitropin alfa 225 IU/day as starting doses yielded similar ovarian responses in women undergoing ovarian stimulation for in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), according to the ADAPT-1 trial presented at ESHRE 2025.

Follitropin delta as good as follitropin alfa for ovarian stimulation in IVF

First-of-its-kind microcatheter for targeted endovascular interventions

A first-of-its-kind submillimeter magnetically actuated soft rotatable-tipped microcatheter (MSRM) developed by a cross-disciplinary research team from the Chinese University of Hong Kong (CUHK) may potentially provide faster, safer, and more precise solution for treating life-threatening blood vessel blockages in the brain.

First-of-its-kind microcatheter for targeted endovascular interventions

Tumour vaccines show potential for glioma treatment

Research on vaccine therapies for glioma has advanced markedly in recent years, with >100 glioma vaccine clinical trials currently ongoing worldwide, according to a recent update review.

Tumour vaccines show potential for glioma treatment

DeLLphi-304: Tarlatamab bests SoC chemo as 2L treatment for SCLC

Tarlatamab was associated with significant improvements in overall survival (OS), progression-free survival (PFS) and patient-reported outcomes (PROs) vs standard-of-care (SoC) chemotherapy in patients with small-cell lung cancer (SCLC) undergoing second-line (2L) therapy, according to the primary analysis of the phase III DeLLphi-304 study presented at ASCO 2025.

DeLLphi-304: Tarlatamab bests SoC chemo as 2L treatment for SCLC

07 Aug 2025

More walking, less low back pain issues

06 Aug 2025 by

Walking a longer distance or for a longer time can reduce the risk of developing chronic low back pain.

More walking, less low back pain issues

Sexual function reduced in people with multiple sclerosis

People with multiple sclerosis (MS) tend to experience a lower sexual function (SF) than healthy individuals, reports a study. Age, depression, disease duration, and the Expanded Disability Status Scale (EDSS) influence SF.

Sexual function reduced in people with multiple sclerosis

POIS treatment must consider symptoms, outcomes: study

06 Aug 2025 by

Examining the symptoms experienced by patients with postorgasmic illness syndrome (POIS) can help improve treatment and resolve these symptoms, suggests a study.

POIS treatment must consider symptoms, outcomes: study